Zhejiang Shouxiangu Pharm Co (603896.SS) stock: key figures, P/E, revenue and dividend

Consumer Staples · Personal Care Products · China · ISIN CNE100002XJ4

Price
13.70 CNY
Market cap
2.72 bn CNY
P/E (2025)
149.44
P/S (2025)
4.24
Dividend yield
0.00 %
Net margin
2.84 %
Return on equity (ROE)
0.80 %
Return on assets (ROA)
0.55 %

Zhejiang Shouxiangu Pharm Co financials

Fiscal year20242025
Revenue691.68 m CNY640.18 m CNY
Gross profit558.34 m CNY503.63 m CNY
Operating income175.26 m CNY123.90 m CNY
EBIT189.79 m CNY126.35 m CNY
Net income174.71 m CNY18.17 m CNY
Diluted EPS – continuing operations0.88 CNY0.09 CNY

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Zhejiang Shouxiangu Pharm Co

Zhejiang Shouxiangu Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the breeding, cultivation, processing, and sale of Chinese medicinal herbs in China and internationally. The company offers ganoderma lucidum spore powder, dendrobium officinale, and saffron products, as well as health and ordinary food, agricultural and sideline products, personal and skincare, and traditional Chinese medicines under the Shouxiangu brand name. It is also involved in the wholesale and retail; technology research and development; and real estate business. The company was founded in 1909 and is headquartered in Jinhua, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.